Literature DB >> 7854166

Influence of the sympathetic nervous system on insulin sensitivity and adipose tissue metabolism: a study in spinal cord-injured subjects.

A K Karlsson1, S Attvall, P A Jansson, L Sullivan, P Lönnroth.   

Abstract

To evaluate insulin sensitivity and adipose tissue metabolism, seven spinal cord-injured (SCI) subjects (age, 43 +/- 6 years; body mass index, 22.8 +/- 1.4; mean +/- SE) and their seven siblings (age, 45 +/- 6 years; body mass index, 24.8 +/- 0.8) were studied using oral glucose (100-g) tolerance tests (OGTTs), euglycemic insulin clamps (insulin infusion, 1 mU/kg.min), and microdialysis of the subcutaneous tissue. Blood glucose and insulin after oral glucose were significantly increased in SCI subjects as compared with their siblings. During insulin clamping, plasma adrenaline increased significantly in controls, but not in SCI subjects. However, the rates of glucose production (2.02 +/- 0.36 v 1.59 +/- 0.09 mg/kg.min) and utilization (5.13 +/- 0.71 v 5.78 +/- 0.34) were similar in the two groups. Furthermore, interstitial subcutaneous glycerol and lactate concentrations before and after oral glucose were similar in the two groups, even in neurally decentralized tissue with broken connection between the central nervous system and peripheral sympathetic nerves. The data suggest that (1) well-mobilized SCI subjects show minor insulin resistance, and (2) sympathetic nervous activity has a minor influence on adipose tissue metabolism in the postabsorptive state, but may affect insulin sensitivity during euglycemic clamping.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7854166     DOI: 10.1016/0026-0495(95)90289-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Contributors to Metabolic Disease Risk Following Spinal Cord Injury.

Authors:  Daniel L Smith; Ceren Yarar-Fisher
Journal:  Curr Phys Med Rehabil Rep       Date:  2016-07-06

2.  Intraneural stimulation elicits an increase in subcutaneous interstitial glycerol levels in humans.

Authors:  C Dodt; P Lonnroth; H L Fehm; M Elam
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

3.  Cardiovascular disease and spinal cord injury: results from a national population health survey.

Authors:  Jacquelyn J Cragg; Vanessa K Noonan; Andrei Krassioukov; Jaimie Borisoff
Journal:  Neurology       Date:  2013-07-24       Impact factor: 9.910

4.  Role of the sympathoadrenergic system in adipose tissue metabolism during exercise in humans.

Authors:  B Stallknecht; J Lorentsen; L H Enevoldsen; J Bülow; F Biering-Sørensen; H Galbo; M Kjaer
Journal:  J Physiol       Date:  2001-10-01       Impact factor: 5.182

Review 5.  Exercise recommendations for individuals with spinal cord injury.

Authors:  Patrick L Jacobs; Mark S Nash
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 6.  Nutritional Health Considerations for Persons with Spinal Cord Injury.

Authors:  Gregory Bigford; Mark S Nash
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

Review 7.  Exercise Interventions Targeting Obesity in Persons With Spinal Cord Injury.

Authors:  David W McMillan; Jennifer L Maher; Kevin A Jacobs; Mark S Nash; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

Review 8.  Neurogenic Obesity and Skeletal Pathology in Spinal Cord Injury.

Authors:  David W McMillan; Mark S Nash; David R Gater; Rodrigo J Valderrábano
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

9.  Alterations in mouse hypothalamic adipokine gene expression and leptin signaling following chronic spinal cord injury and with advanced age.

Authors:  Gregory E Bigford; Valerie C Bracchi-Ricard; Mark S Nash; John R Bethea
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

10.  The SCI Exercise Self-Efficacy Scale (ESES): development and psychometric properties.

Authors:  Thilo Kroll; Matthew Kehn; Pei-Shu Ho; Suzanne Groah
Journal:  Int J Behav Nutr Phys Act       Date:  2007-08-30       Impact factor: 6.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.